Venlafaxine Hydrochloride Patent Expiration

Venlafaxine Hydrochloride is Used for treating depression, generalized anxiety disorder, panic disorder, and social anxiety disorder. It was first introduced by Wyeth Pharmaceuticals Inc in its drug Effexor on Dec 28, 1993. Other drugs containing Venlafaxine Hydrochloride are Venlafaxine Hydrochloride, Effexor Xr. 42 different companies have introduced drugs containing Venlafaxine Hydrochloride.


Venlafaxine Hydrochloride Patents

Given below is the list of patents protecting Venlafaxine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Effexor Xr US6274171

(Pediatric)

Extended release formulation of venlafaxine hydrochloride Sep 20, 2017

(Expired)

Upjohn
Effexor Xr US6403120

(Pediatric)

Extended release formulation of venlafaxine hydrochloride Sep 20, 2017

(Expired)

Upjohn
Effexor Xr US6419958

(Pediatric)

Extended release formulation of venlafaxine hydrochloride Sep 20, 2017

(Expired)

Upjohn
Effexor Xr US6274171 Extended release formulation of venlafaxine hydrochloride Mar 20, 2017

(Expired)

Upjohn
Effexor Xr US6403120 Extended release formulation of venlafaxine hydrochloride Mar 20, 2017

(Expired)

Upjohn
Effexor Xr US6419958 Extended release formulation of venlafaxine hydrochloride Mar 20, 2017

(Expired)

Upjohn
Venlafaxine Hydrochloride US6403120 Extended release formulation of venlafaxine hydrochloride Mar 20, 2017

(Expired)

Osmotica Pharm Us
Venlafaxine Hydrochloride US6419958 Extended release formulation of venlafaxine hydrochloride Mar 20, 2017

(Expired)

Osmotica Pharm Us
Effexor Xr US5916923

(Pediatric)

Venlafaxine for the treatment of generalized anxiety disorder Dec 28, 2013

(Expired)

Upjohn
Effexor Xr US6444708

(Pediatric)

Treatment using venlafaxine Dec 28, 2013

(Expired)

Upjohn
Effexor Xr US5916923 Venlafaxine for the treatment of generalized anxiety disorder Jun 28, 2013

(Expired)

Upjohn
Effexor Xr US6310101 Treatments using venlafaxine Jun 28, 2013

(Expired)

Upjohn
Effexor Xr US6444708 Treatment using venlafaxine Jun 28, 2013

(Expired)

Upjohn



Venlafaxine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Venlafaxine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Venlafaxine Hydrochloride. The first generic version for Venlafaxine Hydrochloride was by Teva Pharmaceuticals Usa Inc and was approved on Aug 3, 2006. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Jun 6, 2024.

Given below is the list of companies who have filed for Venlafaxine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

tablet, extended release Prescription ORAL AB Apr 12, 2023
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Apr 12, 2023
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Apr 12, 2023
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Apr 12, 2023


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





2. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Jun 6, 2024
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Jun 6, 2024
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Jun 6, 2024


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Vadodara Alembic Pharmaceuticals, Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)





3. ALEMBIC PHARMS LTD

Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Dec 14, 2010
EQ 100MG BASE

tablet Prescription ORAL AB Dec 14, 2010
EQ 25MG BASE

tablet Prescription ORAL AB Dec 14, 2010
EQ 37.5MG BASE

tablet Prescription ORAL AB Dec 14, 2010
EQ 75MG BASE

tablet Prescription ORAL AB Dec 14, 2010





4. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

tablet, extended release Prescription ORAL AB Jun 10, 2021
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Jun 10, 2021
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Jun 10, 2021
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Jun 10, 2021





5. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A May 11, 2010
EQ 37.5MG BASE

tablet Discontinued ORAL N/A May 11, 2010
EQ 50MG BASE

tablet Discontinued ORAL N/A May 11, 2010
EQ 75MG BASE

tablet Discontinued ORAL N/A May 11, 2010
EQ 100MG BASE

tablet Discontinued ORAL N/A May 11, 2010





6. ANCHEN PHARMS

Anchen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Anchen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule, extended release Discontinued ORAL N/A Mar 16, 2012
EQ 37.5MG BASE

capsule, extended release Discontinued ORAL N/A Mar 16, 2012
EQ 150MG BASE

capsule, extended release Discontinued ORAL N/A Mar 16, 2012





7. ANNORA PHARMA

Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Annora Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Jul 8, 2019
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Jul 8, 2019
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Jul 8, 2019


Manufacturing Plant Locations
New

Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.

Country City Firm Name
India
Hyderabad Annora Pharma Private Limited





8. APPCO

Appco Pharma Llc has filed for 2 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Appco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Jun 30, 2021
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Jun 30, 2021


Manufacturing Plant Locations
New

Appco's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Appco as present at those locations.

Country City Firm Name
United States
Piscataway Appco Pharma LLC
Somerset Appco Pharma, LLC





9. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Oct 21, 2020
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Oct 21, 2020
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Oct 21, 2020
EQ 37.5MG BASE

tablet, extended release Prescription ORAL AB Oct 21, 2020





10. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Apr 7, 2010
EQ 25MG BASE

tablet Prescription ORAL AB Apr 7, 2010
EQ 100MG BASE

tablet Prescription ORAL AB Apr 7, 2010
EQ 75MG BASE

tablet Prescription ORAL AB Apr 7, 2010
EQ 37.5MG BASE

tablet Prescription ORAL AB Apr 7, 2010


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





11. AUROBINDO PHARMA LTD

Aurobindo Pharma Limited has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





12. CADILA PHARMS LTD

Cadila Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Cadila Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Nov 21, 2018
EQ 50MG BASE

tablet Prescription ORAL AB Nov 21, 2018
EQ 37.5MG BASE

tablet Prescription ORAL AB Nov 21, 2018
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Aug 29, 2019
EQ 100MG BASE

tablet Prescription ORAL AB Nov 21, 2018
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Aug 29, 2019
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Aug 29, 2019





13. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 37.5MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 50MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 75MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 100MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008





14. DEXCEL

Dexcel Pharma Technologies Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dexcel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Oct 31, 2019
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Oct 31, 2019
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Jan 21, 2021


Manufacturing Plant Locations
New

Dexcel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Dexcel as present at those locations.

Country City Firm Name
Israel
Or Akiva Dexcel Pharma Ltd.
Yokne'Am Ilit Dexcel Pharma Technologies - Yokneam Factory





15. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 6 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB May 6, 2011
EQ 50MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 75MG BASE

capsule, extended release Prescription ORAL AB May 6, 2011
EQ 100MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 150MG BASE

capsule, extended release Prescription ORAL AB May 6, 2011





16. GRANULES

Granules India Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB May 18, 2023
EQ 150MG BASE

capsule, extended release Prescription ORAL AB May 18, 2023
EQ 75MG BASE

capsule, extended release Prescription ORAL AB May 18, 2023


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Chantilly Granules Pharmaceuticals Inc.
Manassas Granules Consumer Health Inc.
India
Parawada Mandal Granules India Limited
Sangareddy District Granules India Limited
Visakhapatnam Granules India Limited
Medchal-Malkhajgiri District Granules India Limited
Secunderabad Granules India Limited





17. HERITAGE

Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Heritage.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB Jan 9, 2009
EQ 25MG BASE

tablet Prescription ORAL AB Jan 9, 2009
EQ 37.5MG BASE

tablet Prescription ORAL AB Jan 9, 2009
EQ 50MG BASE

tablet Prescription ORAL AB Jan 9, 2009
EQ 75MG BASE

tablet Prescription ORAL AB Jan 9, 2009


Manufacturing Plant Locations
New

Heritage's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage as present at those locations.

Country City Firm Name
United States
Sacramento Heritage Baking Company Inc.
Caldwell Heritage Country Store-Heritage Cooperative
Kenton Heritage Cooperative
Fort Scott Heritage Acres Farm
Upper Sandusky Heritage Cooperative
Chino Heritage #2
Lisbon Heritage Cooperative, Inc.
Woodsfield Heritage Cooperative
Cairo Heritage Cooperative
South Burlington Heritage Aviation
De Graff Heritage Cooperative Inc
Middlebury Heritage Acres
Waterford Heritage Cooperative
New Philadelphia Heritage Cooperative
Van Nuys Heritage Candy Company, Inc.
London Heritage Cooperative Inc.
Springfield Heritage Cooperative, Inc
Ada Heritage Cooperative Inc
West Mansfield Heritage Cooperative Inc.
Richwood Heritage Cooperative, Inc
Plain City Heritage Cooperative Inc.
Minneapolis Heritage Deli Provisions, LLC
London Heritage Cooperative, Inc
Dola Heritage Cooperative Inc
Canfield Heritage Cooperative
Alger Heritage Cooperative
Beloit Heritage Cooperative
Mc Cutchenville Heritage Cooperative, Inc
Vanlue Heritage Cooperative
Fletcher Heritage Cooperative Inc
West Liberty Heritage Cooperative, Inc
Urbana Heritage Cooperative Inc
Morgantown Heritage Animal Hospital





18. INTELLIPHARMACEUTICS

Intellipharmaceutics Corp has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Intellipharmaceutics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Nov 23, 2018
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Nov 23, 2018
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Nov 23, 2018


Manufacturing Plant Locations
New

Intellipharmaceutics's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Intellipharmaceutics as present at those locations.

Country City Firm Name
Canada
Etobicoke IntelliPharmaCeutics Corp.





19. INVENTIA HLTHCARE

Inventia Healthcare Private Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Inventia Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Mar 12, 2020
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Mar 12, 2020
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Mar 12, 2020





20. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Oct 5, 2017
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Oct 5, 2017
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Oct 5, 2017





21. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 6 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 37.5MG BASE

capsule, extended release Discontinued ORAL N/A Jun 1, 2011
EQ 50MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 75MG BASE

capsule, extended release Discontinued ORAL N/A Jun 1, 2011
EQ 100MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 150MG BASE

capsule, extended release Discontinued ORAL N/A Jun 1, 2011





22. NOSTRUM LABS INC

Nostrum Laboratories Inc has filed for 2 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Mar 24, 2017
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Mar 24, 2017





23. NOSTRUM PHARMS LLC

Nostrum Pharmaceuticals Llc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Nostrum Pharms Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

capsule, extended release Discontinued ORAL N/A Apr 4, 2023
EQ 75MG BASE

capsule, extended release Discontinued ORAL N/A Apr 4, 2023
EQ 150MG BASE

capsule, extended release Discontinued ORAL N/A Apr 4, 2023





24. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Jul 11, 2011
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Jul 11, 2011
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Jul 11, 2011





25. PLIVA HRVATSKA DOO

Pliva Hrvatska Doo has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Pliva Hrvatska Doo.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 25MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 37.5MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 75MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008
EQ 100MG BASE

tablet Discontinued ORAL N/A Jun 13, 2008





26. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

tablet Discontinued ORAL N/A Aug 4, 2010
EQ 50MG BASE

tablet Discontinued ORAL N/A Aug 4, 2010
EQ 100MG BASE

tablet Discontinued ORAL N/A Aug 4, 2010
EQ 75MG BASE

tablet Discontinued ORAL N/A Aug 4, 2010
EQ 25MG BASE

tablet Discontinued ORAL N/A Aug 4, 2010





27. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Aug 18, 2010
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Aug 18, 2010
EQ 37.5MG BASE

tablet, extended release Prescription ORAL AB Aug 18, 2010
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Jan 8, 2019


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Billerica Sun Pharmaceutical Industries, Inc.
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
India
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Ahmednagar Sun Pharmaceutical Industries Limited
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Mohali Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Baruch Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Dadra Sun Pharmaceutical Industries Limited
Bharuch Sun Pharmaceutical Industries Ltd





28. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 37.5MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 50MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 75MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 100MG BASE

tablet Prescription ORAL AB Jun 13, 2008





29. SWISS PHARM

Swiss Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Swiss Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet, extended release Discontinued ORAL N/A Jan 4, 2022
EQ 150MG BASE

tablet, extended release Discontinued ORAL N/A Jan 4, 2022


Manufacturing Plant Locations
New

Swiss Pharm's manufacturing plants are situated in 1 country - Taiwan. Given below are the details of these plant locations as well as the firm names of Swiss Pharm as present at those locations.

Country City Firm Name
Taiwan
Tainan City Swiss Pharmaceutical Company Ltd





30. TEVA

Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Jun 28, 2010
EQ 100MG BASE

tablet Prescription ORAL AB Aug 3, 2006
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Jun 28, 2010
EQ 25MG BASE

tablet Prescription ORAL AB Aug 3, 2006
EQ 50MG BASE

(reference standard)

tablet Prescription ORAL AB Aug 3, 2006
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Jun 28, 2010


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
Fort Dodge TEVA Animal Health Inc
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Scarborough Teva Canada Limited
Markham Teva Canada Limited
Stouffville Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





31. TORRENT

Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

capsule, extended release Discontinued ORAL N/A Jun 1, 2011
EQ 75MG BASE

capsule, extended release Discontinued ORAL N/A Jun 1, 2011
EQ 150MG BASE

capsule, extended release Discontinued ORAL N/A Jun 1, 2011


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Bharuch Torrent Pharmaceuticals Limited
Pithampur Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
United States
Kalamazoo Torrent Pharma Inc.
Basking Ridge Torrent Pharma Inc.





32. UNIQUE

Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Unique.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Nov 28, 2022
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Nov 28, 2022
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Nov 28, 2022
EQ 37.5MG BASE

tablet, extended release Prescription ORAL AB Nov 28, 2022


Manufacturing Plant Locations
New

Unique's manufacturing plants are situated in 5 countries - United States, India, Canada, Portugal, Taiwan. Given below are the details of these plant locations as well as the firm names of Unique as present at those locations.

Country City Firm Name
United States
Landing Unique Encapsulation Technology, LLC
Everett Unique sushi
Cumberland Unique Soy Products International, LLC
Norman Unique Confections LLC
Garner Unique Food Company
Ottawa Uniquely Emu Products, Inc.
Nashville Unique Surgical Inc
Concord Unique Molded Foam Technologies, Inc.
Bridgeport Unique Instruments, Inc.
Bisbee Unique Coffee, LLC
Gold Canyon Unique Ingredients LLC.
Chatsworth Unique Laboratories, Inc.
Cypress Unique Distributors, Inc. dba Florentino Ice Cream
Brownsville Unique Candies Llc
Richmond Hill Unique Importer & Distributor Inc.
India
Surat Unique Hospital- Multispecialty & Research Institute
Sonepat Unique Fragrances
Ankleshwar Unique Chemicals
Bharuch Unique Pharmaceutical Laboratories (A Division of J. B. Chemicals & Pharmaceuticals Ltd)
New Delhi Unique Fragrances
Navi Mumbai Unique Chemicals
Canada
Cambridge Unique Global Product and Distribution Inc.
Portugal
Velas Uniqueijo - Uniao de Cooperativas Agricolas de Lacticinios de Sao Jorge, UCRL
Taiwan
Toucheng Township Unique Safety Equipment Co., Ltd





33. VALEANT PHARMS NORTH

Valeant Pharmaceuticals North America Llc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Valeant Pharms North.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule, extended release Discontinued ORAL N/A Apr 15, 2011
EQ 37.5MG BASE

capsule, extended release Discontinued ORAL N/A Apr 15, 2011
EQ 150MG BASE

capsule, extended release Discontinued ORAL N/A Apr 15, 2011





34. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011





35. YAOPHARMA CO LTD

Yaopharma Co Ltd has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Yaopharma Co Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Prescription ORAL AB May 28, 2015
EQ 50MG BASE

tablet Prescription ORAL AB May 28, 2015
EQ 37.5MG BASE

tablet Prescription ORAL AB May 28, 2015
EQ 25MG BASE

tablet Prescription ORAL AB May 28, 2015
EQ 75MG BASE

tablet Prescription ORAL AB May 28, 2015


Manufacturing Plant Locations
New

Yaopharma Co Ltd's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yaopharma Co Ltd as present at those locations.

Country City Firm Name
China
Yubei Yaopharma Co Ltd





36. YICHANG HUMANWELL

Yichang Humanwell Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Aug 6, 2021
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Aug 6, 2021
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Aug 6, 2021


Manufacturing Plant Locations
New

Yichang Humanwell's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yichang Humanwell as present at those locations.

Country City Firm Name
China
Yichang Yichang Humanwell Oral Solid Dosage Plant





37. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 225MG BASE

tablet, extended release Prescription ORAL AB Aug 30, 2022
EQ 37.5MG BASE

tablet, extended release Prescription ORAL AB Aug 30, 2022
EQ 75MG BASE

tablet, extended release Prescription ORAL AB Aug 30, 2022
EQ 150MG BASE

tablet, extended release Prescription ORAL AB Aug 30, 2022





38. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 37.5MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 50MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 75MG BASE

tablet Prescription ORAL AB Jun 13, 2008
EQ 100MG BASE

tablet Prescription ORAL AB Jun 13, 2008





39. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Venlafaxine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 37.5MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011
EQ 75MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011
EQ 150MG BASE

capsule, extended release Prescription ORAL AB Apr 14, 2011